CoChat

Pomegranate’s Neuroprotective Effects against Alzheimer’s Disease Are Mediated by Urolithins, Its Ellagitannin-Gut Microbial Derived Metabolites

Open access

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Pomegranate shows neuroprotective effects against Alzheimer's disease (AD) in several reported animal studies. However, whether its constituent ellagitannins and/or their physiologically relevant gut microbiota-derived metabolites, namely, urolithins (6H-dibenzo[b,d]pyran-6-one derivatives), are the responsible bioactive constituents is unknown. Therefore, from a pomegranate extract (PE), previously reported by our group to have anti-AD effects in vivo, 21 constituents, which were primarily ellagitannins, were isolated and identified (by HPLC, NMR, and HRESIMS). In silico computational studies, used to predict blood-brain barrier permeability, revealed that none of the PE constituents, but the urolithins, fulfilled criteria required for penetration. Urolithins prevented β-amyloid fibrillation in vitro and methyl-urolithin B (3-methoxy-6H-dibenzo[b,d]pyran-6-one), but not PE or its predominant ellagitannins, had a protective effect in Caenorhabditis elegans post induction of amyloid β(1-42) induced neurotoxicity and paralysis. Therefore, urolithins are the possible brain absorbable compounds which contribute to pomegranate's anti-AD effects warranting further in vivo studies on these compounds.

Overview

Integrity signals

Registry

Crossref · 10.1021/acschemneuro.5b00260

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 4

  1. Tomás-Barberan F. A., 2009, Flavonoids and Related Compounds: Bioavailability and Function, 183
  2. Seeram N. P., 2006, Pomegranate: Ancient roots to modern medicine, 3
  3. Zhexiong J., 2014, J. Chem. Pharm. Res., 6, 1770
  4. de Fátima Bezerra M., 2014, Int. J. Appl. Res. Nat. Prods., 7, 39

Cited by

See all 224

Metadata

Authors
Yuan, T., Ma, H., Liu, W., Niesen, D. B., Shah, N., Crews, R., Rose, K. N., Vattem, D. A., & Seeram, N. P.
Affiliations
  • University of Rhode Island (US)
  • Texas State University (US)
Corresponding author
Seeram, Navindra P.
Venue
ACS Chemical Neuroscience
Published
2015-11-17
Volume
7
Issue
1
Pages
26-33
ISSN
1948-7193 (ISSN-L)
OpenAlex
W2270905116
Cited by
219
References
44
Citations by year
2026: 13 · 2025: 13 · 2024: 14 · 2023: 19 · 2022: 31 · 2021: 39 · 2020: 33 · 2019: 26 · 2018: 12 · 2017: 11 · 2016: 7
FWCI
9.63
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • ACS Chemical Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • Journal of Media Literacy Education (submittedVersion, cc-by)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Pomegranate: compositions and health benefits
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Keywords
Punica granatum, Alzheimer's disease, neuroprotection, urolithins, ellagitannins, gut microbiota metabolites, amyloid-beta fibrillation, blood-brain barrier permeability, Caenorhabditis elegans, neurotoxicity, bioactive compounds
MeSH terms
Age Factors, Alzheimer Disease, Animals, Biophysics, Blood-Brain Barrier, Chromatography, Liquid, Computer Simulation, Coumarins, Disease Models, Animal, Dose-Response Relationship, Drug, Humans, Models, Biological, Peptide Fragments, Mass Spectrometry, Amyloid beta-Peptides, Caenorhabditis elegans, Neuroprotective Agents, Lythraceae, Animals, Genetically Modified, Hydrolyzable Tannins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.